AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers.
AbTx platform is developing mAb innovative enzymatic conjugation.
Our platform unlock New Frontiers in Medicine to overcome ADC major drawbacks associated targeting solid tumors by generating antibody Fragment Drug Conjugates (FDCs).
Company Details
- Employees
- 5
- Founded
- 2024
- Address
- 64, Rue Sully, Dijon,bourgogne-Franche-Comté 21000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abtx-bio.com
- Keywords
- ADC, Oncology, drug develoment.
- HQ
- Dijon, Bourgogne-Franche-Comté
Abtx Questions
Abtx's website is http://www.abtx-bio.com
Abtx's LinkedIn profile is https://fr.linkedin.com/company/abtx
Abtx has
5 employees.
View email and phone details for 5
employees at Abtx.
Abtx's industry is
Biotechnology Research
Abtx's top competitors are
Peektoria,
Phaxiam Therapeutics,
Serendip Innovations,
Priothera Sas,
Carla Biotherapeutics,
Orinova,
Covalab,
Mabdesign,
Bioclonal,
Theranovir.
Abtx's categories are Biotechnology Research
Abtx's founding year is 2024
